Drugs Made In America Acquisition Corp. Ordinary Shares

NASDAQ:DMAA

Shell Companies

Financial Services
$10.90 +0.00%

+$0.00 today

Market cap
$264.62M
Beta
0.00
P/E (TTM)
36.7
EPS (TTM)
$0.29
52W Low $10.17High $10.63

Volume 0.00M

Average 0.11M

DMAA Net Income

Bottom-line profit, the starting point for calculating cash from operations.

Drugs Made In America Acquisition Corp. Ordinary SharesNASDAQ: DMAA

Net Income · Q1 FY2026 · quarter ended Mar 2026

Net income grows, but more slowly than its trailing trend

Q1 FY2026 net income of $1.97M rose 57.1% year over year, behind the +322.2% change in trailing-twelve-month net income.

What to watch

Whether quarterly growth recovers from +57.1% toward the trailing-twelve-month pace of +322.2%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
$1.97M+211.9% QoQ
Last fiscal yearDec 2025
$3.97M+828321.9% YoY
LTMMar 2026
$4.68M+322.2% YoY
Net Income past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+57.1%——
1 year+828321.9%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Net Income history

USD · from the cash flow

Latest · FY2025
3.97M USD
Year-over-year change
+828321.9%

Net Income vs competitors

How DMAA compares with its peers on the latest reported figures

  • DMAA's LTM Mar 2026 net income of $4.68M is the smallest of the 10 companies compared; the peer median is $7.88M.
  • Its year-over-year change of +322.2% is the lowest of 5, against a peer median of +1808013.6%.
DMAA Competitors Peer median
Net Income for DMAA and competitors
Company Period LTM YoY 3-year CAGR% of revenue
LOKVLive Oak Acquisition Corp. V Class A Ordinary SharesFY2025$16.5M +7430251.8%——
ALFCenturion Acquisition Corp.LTM Mar 2026$10.86M ———
TACHTitan Acquisition Corp.LTM Mar 2026$9.16M +3614258.3%——
SIMASIM Acquisition Corp. ILTM Mar 2026$8.6M +334.9%——
MLACMountain Lake Acquisition Corp.FY2025$8.28M +1769.0%+40.2%—
TACOUBerto Acquisition Corp. UnitFY2025$7.88M ———
TACOBerto Acquisition Corp.FY2025$7.88M ———
RTACRenatus Tactical Acquisition Corp I Class A Ordinary SharesLTM Mar 2026$6.47M ———
OYSEOyster Enterprises II Acquisition CorpFY2025$5.78M ———
DMAADrugs Made In America Acquisition Corp. Ordinary SharesLTM Mar 2026$4.68M +322.2%——
Peer median (excluding DMAA) $7.88M+1808013.6%+40.2%—

Competitors are the stored peer set for DMAA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Drugs Made In America Acquisition Corp. Ordinary Shares

NASDAQ:DMAA

Intrinsic Alpha fair value

Locked

Current Price

$10.90

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.